MARC2 抗体 (AA 270-300)
Our Local Distributor
北京 101111
Quick Overview for MARC2 抗体 (AA 270-300) (ABIN7873150)
抗原
See all MARC2 抗体适用
宿主
克隆类型
标记
应用范围
-
-
抗原表位
- AA 270-300
-
原理
- Mitochondrial amidoxime reducing component 2 Antibody / mARC2 / MTARC2
-
纯化方法
- Antigen affinity purified
-
免疫原
- A portion of amino acids 270-300 from the human protein was used as the immunogen for the Mitochondrial amidoxime reducing component 2 antibody.
-
亚型
- Ig Fraction
-
-
-
-
应用备注
- The stated application concentrations are suggested starting points. Titration of the Mitochondrial amidoxime reducing component 2 antibody may be required due to differences in protocols and secondary/substrate sensitivity.
-
限制
- 仅限研究用
-
-
-
状态
- Liquid
-
缓冲液
- In 1X PBS, pH 7.4, with 0.09 % sodium azide
-
储存液
- Sodium azide
-
注意事项
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
储存条件
- -20 °C
-
储存方法
- Aliquot the Mitochondrial amidoxime reducing component 2 antibody and store frozen at -20oC or colder. Avoid repeated freeze-thaw cycles.
-
-
- MARC2 (Mitochondrial Amidoxime Reducing Component 2 (MARC2))
-
别名
- Mitochondrial amidoxime reducing component 2
-
背景
- Catalytic component of the benzamidoxime prodrug-converting complex, a complex required to reduce N-hydroxylated structures, such as benzamidoxime prodrug. Benzamidoxime is an amidine prodrug produced by N-hydroxylation which is used to enhance bioavailability and increase intestinal absorption. It is then reduced into benzamidine, its active amidine, by the benzamidoxime prodrug-converting complex.
-
UniProt
- Q969Z3
抗原
-